Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics. [electronic resource]
Producer: 20110120Description: 97-104 p. digitalISSN:- 1532-6535
- Biomarkers, Pharmacological -- blood
- Cell Line
- Chromosomes, Human, Pair 9 -- genetics
- Citalopram -- therapeutic use
- DNA-Binding Proteins -- metabolism
- Depressive Disorder, Major -- blood
- Drug Monitoring -- methods
- Female
- Genetic Association Studies
- Glycine -- blood
- Glycine Dehydrogenase (Decarboxylating) -- genetics
- Humans
- Introns -- genetics
- Linkage Disequilibrium
- Male
- Metabolome -- drug effects
- Nuclear Proteins -- metabolism
- Polymorphism, Single Nucleotide
- Selective Serotonin Reuptake Inhibitors -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study
There are no comments on this title.
Log in to your account to post a comment.